Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2026
SK signs $315M pact with fellow South Korean company for Parkinson's drug candidate
SK entered a $315M pact with a fellow South Korean company concerning a Parkinson's disease drug candidate, as reported by Fierce Biotech.
2021
SK and Monolith sign MOU to establish South Korean joint venture
SK and Monolith Materials signed an MOU to establish a South Korean joint venture producing green hydrogen and carbon black. Monolith will provide technology and training, while SK will oversee production, sales and distribution.
2021
SK completes acquisition of Yposkesi
SK completed its acquisition of French drug manufacturer Yposkesi, acquiring a 70% stake including management rights. Yposkesi will be operated by SK Pharmteco, an SK Inc. subsidiary.
2019
CODE42 raises KRW 30 billion in Pre-A funding
CODE42 announced that it had raised KRW 30 billion (USD 25 million) in Pre-A funding, with investment from Kia Motors, SK, LG, and CJ.